据新华社电中国中山大学研究人员7日在美国报告说，其自主研发的新药康柏西普可明显提高湿性老年黄斑变性患者的视力。 中山大学中山眼科中心的丁小燕教授当天在迈阿密举行的一个眼底病国际会议上报告说，共有30名晚期湿性黄斑变性老年患者参与了一项历时3年的研究试验，这些人平均年龄69岁，其最佳矫...
AP China Zhongshan University researchers report in 7 days American said, the independent research and development of new drug Compaq Xipu can significantly improve the wet age-related macular degeneration patients eyesight. Report of Ophthalmological Center of Zhongshan University professor Ding Xiaoyan was held in Miami on the day of an ocular fundus disease international conference said, a total of 30 advanced wet macular degeneration in aged patients involved in the study tests for 3 years a diachronic, these people with an average age of 69, its best straightening...
